Blog Standard Full Width - Kan and Krishme

July 25, 2025
Blog
No Comments

Protecting IP in a Global Market: Delhi HC’s Strategic Use of Section 151 CPC

Introduction The Delhi High Court recently addressed a pressing issue in Communication Components Antenna Inc. v. Ace Technologies Corp. and Ors1: how can Indian patent holders enforce their rights when foreign infringers have no assets in India? The case involved a cross-border patent dispute where the defendants, based in South Korea and Hong Kong, were […]

July 18, 2025
Blog
No Comments

Delhi High Court Reiterates Limits on Patentability of Software-Based Inventions

On July 1, 2025, in Kroll Information Assurance, LLC v. The Controller General of Patents, Designs and Trademarks & Ors.1, the Delhi High Court upheld the refusal of a patent application under Section 3(k) of the Indian Patents Act, 1970, reaffirming that a mere sequence of instructions or abstract profiling logic is insufficient for patent […]

July 18, 2025
Blog
No Comments

MS Dhoni’s Quest to Trademark “Captain Cool”

In June 2023, legendary former Indian cricket captain Mahendra Singh Dhoni took a significant step by filing a trademark application for his well-known nickname, “Captain Cool.” The application was submitted by Rithi Sports Management Pvt Ltd, a company associated with Dhoni, to the Trade Marks Registry. The mark was filed under Class 41, which covers […]

July 18, 2025
Blog
No Comments

Delhi High Court Stays Multimillion Dollar Decree against Amazon

Introduction On July 1, 2025, the Delhi High Court passed a significant order 1staying the execution of a ₹336 crore (approx. USD 38.8 million) decree awarded against Amazon Technologies Inc. in a trademark infringement suit initiated by Lifestyle Equities CV and Lifestyle Licensing BV—entities associated with the Beverly Hills Polo Club (BHPC) brand. This stay […]

July 11, 2025
Blog
No Comments

How Delay and Non-Use Undid Conqueror’s Claims Against Xiaomi

Introduction How Delay and Non-Use Undid Conqueror’s Claims Against Xiaomi The Delhi High Court’s decision in Conqueror Innovations Private Limited & Anr. v. Xiaomi Technology India Private Limited1 [1] offers a meticulous exploration of patent infringement claims and the high threshold required for interim relief in Indian patent litigation. Justice Amit Bansal’s judgment, pronounced on […]

July 11, 2025
Blog
No Comments

A Weighty Dispute: Novo Nordisk’s Semaglutide Patent Clash in Delhi High Court

Introduction A major patent battle [1] has erupted in India between pharmaceutical giants Novo Nordisk and Dr. Reddy’s Laboratories over the popular weight loss and diabetes drug semaglutide. Novo Nordisk sued Dr. Reddy’s for manufacturing and exporting its patented drug without consent. This case is significant for the Indian pharmaceutical industry, as its outcome will […]

June 30, 2025
Blog
No Comments

Opinion-Trading Ads: MPL Challenges ASCI White Paper, Seeks $6mil in Damages

Opinion-Trading Ads: MPL Challenges ASCI White Paper, Seeks $6mil in Damages On May 23, 2025, Galactus Funware Technology Pvt Ltd, the parent company of Mobile Premier League (MPL), served an 11-page legal notice to the Advertising Standards Council of India (ASCI). The notice demands two principal remedies: (i) immediate withdrawal of ASCI’s white-paper Examining Opinion Trading […]

June 26, 2025
Blog
No Comments

Patentability of Feed Compositions: Madras High Court’s Take on Sections 3(d) & 3(i)

Introduction In KEMIN INDUSTRIES, INC. v. Controller of Patents [1]1, the Madras High Court overturned the rejection of a patent application concerning a method of improving animal feed by supplementing bacterial ferulic acid esterase (FAE) with four specific enzymes. The Patent Office had denied the application under Sections 2(1)(j), 3(d), and 3(i) of the Patents […]

June 26, 2025
Blog
No Comments

Deadline Extensions 101 in Indian Patent Law

Introduction On 15th March 2024, the Indian Patent Office (IPO) published the Patent (Amendment) Rules, 2024. Notably, Rules 137 and 138—relating to the Controller’s powers to condone procedural irregularities and extend deadlines were significantly amended. These changes clarify which specific irregularities can now be condoned by the Controller and which deadlines are eligible for extension. […]

June 20, 2025
Blog
No Comments

No Patent For Intermediates without Efficacy

Introduction On May 27, 2025, in Zeria Pharmaceutical Co. Ltd. v. Deputy Controller of Patents and Designs1, the Delhi High Court upheld the refusal of divisional patent, affirming that minor structural modifications of known pharmaceutical compounds—especially intermediates—must still demonstrate enhanced therapeutic efficacy to be patentable under Section 3(d) of the Indian Patents Act, 1970. The […]